Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.
Primary care consulting for GP practices & PCNs across England. Get in touch →
MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) Drug alert number: EL(26)A/30 Date issued: 29 June 2026 Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were [...]
The post MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) appeared first on Community Pharmacy England.
Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.